Mackenzie Financial
TXG icon

Mackenzie Financial’s 10x Genomics TXG Stock Holding History

Mackenzie Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.6M Buy
+217,444
New +$12.7M 0.02% 461
2025
Q2 		– Sell
-28,251
Closed -$247K – 1800
2025
Q1 		$247K Sell
28,251
-25,139
-47% -$317K ﹤0.01% 1450
2024
Q4 		$767K Buy
53,390
+21,817
+69% +$344K ﹤0.01% 1016
2024
Q3 		$713K Buy
+31,573
New +$653K ﹤0.01% 940
2024
Q2 		– Sell
-13,405
Closed -$503K – 1629
2024
Q1 		$503K Buy
+13,405
New +$589K ﹤0.01% 1024
2022
Q2 		– Sell
-4,191
Closed -$319K – 1549
2022
Q1 		$319K Sell
4,191
-11,527
-73% -$1.01M ﹤0.01% 1089
2021
Q4 		$2.34M Sell
15,718
-6,534
-29% -$1M ﹤0.01% 744
2021
Q3 		$3.24M Buy
22,252
+2,074
+10% +$356K ﹤0.01% 653
2021
Q2 		$3.95M Buy
20,178
+12,831
+175% +$2.32M 0.01% 602
2021
Q1 		$1.33M Buy
7,347
+2,703
+58% +$467K ﹤0.01% 768
2020
Q4 		$658K Buy
+4,644
New +$674K ﹤0.01% 782

Other funds holding TXG

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Counterpoint Mutual Funds
Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Convergence Investment Partners
Convergence Investment Partners Palm Beach Gardens, Florida $1.35B AUM 71.9% 1-Year Est. Return
Cookson Peirce & Co
Cookson Peirce & Co Pittsburgh, Pennsylvania $2.77B AUM 64.09% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Financial Consulate
Financial Consulate Hunt Valley, Maryland $899M AUM 14.82% 1-Year Est. Return
MIC
Maxi Investments CY Limassol, Cyprus $545M AUM 21.2% 1-Year Est. Return

Mackenzie Financial's TXG Position: Q3 2026 in Review

Mackenzie Financial opened a new position in 10x Genomics (TXG) in Q3 2026: 217,444 shares worth $19.6M. The stake represents 0.02% of the portfolio and ranks #461 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in TXG as recently as Q1 2025.

Mackenzie Financial first reported a position in TXG in Q4 2020 and has held it in 11 quarters since. 135 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Mackenzie Financial held 217,444 shares of 10x Genomics worth $19.6M as of Q3 2026.
  • 10x Genomics was a new Mackenzie Financial position in Q3 2026.
  • 10x Genomics made up 0.02% of Mackenzie Financial's portfolio in Q3 2026, its #461 holding.
  • Mackenzie Financial first reported a position in 10x Genomics in Q4 2020 and has held it in 11 quarters since.
  • 135 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.